Plasma Transthyretin Levels and Risk of Type 2 Diabetes Mellitus and Impaired Glucose Regulation in a Chinese Population

Plasma transthyretin may be engaged in glucose regulation. We aimed to investigate the association between plasma transthyretin levels and the risk of newly diagnosed T2DM and impaired glucose regulation (IGR) in a Chinese population. We conducted a case-control study including 1244 newly diagnosed...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nutrients 2022-07, Vol.14 (14), p.2953
Hauptverfasser: Hu, Xiaoli, Guo, Qianqian, Wang, Xiaoqian, Wang, Qiang, Chen, Liangkai, Sun, Taoping, Li, Peiyun, Shan, Zhilei, Liu, Liegang, Gao, Chao, Rong, Ying
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 14
container_start_page 2953
container_title Nutrients
container_volume 14
creator Hu, Xiaoli
Guo, Qianqian
Wang, Xiaoqian
Wang, Qiang
Chen, Liangkai
Sun, Taoping
Li, Peiyun
Shan, Zhilei
Liu, Liegang
Gao, Chao
Rong, Ying
description Plasma transthyretin may be engaged in glucose regulation. We aimed to investigate the association between plasma transthyretin levels and the risk of newly diagnosed T2DM and impaired glucose regulation (IGR) in a Chinese population. We conducted a case-control study including 1244 newly diagnosed T2DM patients, 837 newly diagnosed IGR patients, and 1244 individuals with normal glucose tolerance (NGT) matched by sex and age. Multivariate logistic regression analysis was utilized to estimate the independent association of plasma transthyretin concentrations with the risk of T2DM and IGR. Plasma transthyretin concentrations were significantly higher in T2DM and IGR patients compared with control subjects (p < 0.005). After multiple adjustment and comparison with the lowest quartile of plasma transthyretin concentrations, the odds ratios (95% confidence intervals) of T2DM and IGR in the highest quartile were 2.22 (1.66, 2.98) and 2.29 (1.72, 3.05), respectively. Plasma transthyretin concentrations also showed a great performance in predicting the risk of T2DM (AUC: 0.76). Moreover, a potential nonlinear trend was observed. Our results demonstrated that higher plasma transthyretin concentrations, especially more than 290 mg/L, were associated with an increased risk of T2DM and IGR. Further studies are warranted to confirm our findings and elucidate the potential mechanisms.
doi_str_mv 10.3390/nu14142953
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9321865</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2695289967</sourcerecordid><originalsourceid>FETCH-LOGICAL-c406t-eb64cf9f500643f59a2d874ed24ad4bf8035ab7519f8aa47787fc7fa6f4086213</originalsourceid><addsrcrecordid>eNpdkdFrFDEQxhdRbKl98Q-QgC8iXM0m2WTzIshVa-GKpZzPYXZ30kvdTdZkt3j_vTnuWmvzMmHmx8d88xXF25Keca7pJz-XohRMV_xFccyoYgspBX_55H9UnKZ0R3dPUSX56-KIV3WtdUmPiz_XPaQByDqCT9NmG3FynqzwHvtEwHfkxqVfJFiy3o5IGDl30OCEiVxh37tp3kOXwwguYkcu-rkNCckN3s49TC54kuWALDfOY-5fh_HQf1O8stAnPD3Uk-Lnt6_r5ffF6sfF5fLLatEKKqcFNlK0VtuK0mzFVhpYVyuBHRPQicbWlFfQqKrUtgYQStXKtsqCtILWkpX8pPi81x3nZsCuRT9F6M0Y3QBxawI48__Eu425DfdGc1bWssoCHw4CMfyeMU1mcKnN7sFjmJNhUlcsX1OqjL5_ht6FOfpsb0cJykvFaKY-7qk2hpQi2sdlSmp2mZp_mWb43dP1H9GHBPlftYCdIg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2694031720</pqid></control><display><type>article</type><title>Plasma Transthyretin Levels and Risk of Type 2 Diabetes Mellitus and Impaired Glucose Regulation in a Chinese Population</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>PubMed Central</source><creator>Hu, Xiaoli ; Guo, Qianqian ; Wang, Xiaoqian ; Wang, Qiang ; Chen, Liangkai ; Sun, Taoping ; Li, Peiyun ; Shan, Zhilei ; Liu, Liegang ; Gao, Chao ; Rong, Ying</creator><creatorcontrib>Hu, Xiaoli ; Guo, Qianqian ; Wang, Xiaoqian ; Wang, Qiang ; Chen, Liangkai ; Sun, Taoping ; Li, Peiyun ; Shan, Zhilei ; Liu, Liegang ; Gao, Chao ; Rong, Ying</creatorcontrib><description>Plasma transthyretin may be engaged in glucose regulation. We aimed to investigate the association between plasma transthyretin levels and the risk of newly diagnosed T2DM and impaired glucose regulation (IGR) in a Chinese population. We conducted a case-control study including 1244 newly diagnosed T2DM patients, 837 newly diagnosed IGR patients, and 1244 individuals with normal glucose tolerance (NGT) matched by sex and age. Multivariate logistic regression analysis was utilized to estimate the independent association of plasma transthyretin concentrations with the risk of T2DM and IGR. Plasma transthyretin concentrations were significantly higher in T2DM and IGR patients compared with control subjects (p &lt; 0.005). After multiple adjustment and comparison with the lowest quartile of plasma transthyretin concentrations, the odds ratios (95% confidence intervals) of T2DM and IGR in the highest quartile were 2.22 (1.66, 2.98) and 2.29 (1.72, 3.05), respectively. Plasma transthyretin concentrations also showed a great performance in predicting the risk of T2DM (AUC: 0.76). Moreover, a potential nonlinear trend was observed. Our results demonstrated that higher plasma transthyretin concentrations, especially more than 290 mg/L, were associated with an increased risk of T2DM and IGR. Further studies are warranted to confirm our findings and elucidate the potential mechanisms.</description><identifier>ISSN: 2072-6643</identifier><identifier>EISSN: 2072-6643</identifier><identifier>DOI: 10.3390/nu14142953</identifier><identifier>PMID: 35889910</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Age ; Blood Glucose - analysis ; Body mass index ; Case-Control Studies ; China - epidemiology ; Cholesterol ; Confidence intervals ; Diabetes ; Diabetes mellitus ; Diabetes mellitus (non-insulin dependent) ; Diabetes Mellitus, Type 2 - epidemiology ; Family medical history ; Glucose ; Glucose Intolerance - epidemiology ; Glucose tolerance ; Health risks ; High density lipoprotein ; Homeostasis ; Hospitals ; Humans ; Hypertension ; Insulin resistance ; Lipoproteins ; Nutritional status ; Plasma ; Population ; Prealbumin - analysis ; Proteins ; Regression analysis ; Risk ; Statistical analysis ; Transthyretin</subject><ispartof>Nutrients, 2022-07, Vol.14 (14), p.2953</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c406t-eb64cf9f500643f59a2d874ed24ad4bf8035ab7519f8aa47787fc7fa6f4086213</citedby><cites>FETCH-LOGICAL-c406t-eb64cf9f500643f59a2d874ed24ad4bf8035ab7519f8aa47787fc7fa6f4086213</cites><orcidid>0000-0002-7029-1224 ; 0000-0002-8561-7872 ; 0000-0002-4019-2743</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321865/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321865/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,883,27911,27912,53778,53780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35889910$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hu, Xiaoli</creatorcontrib><creatorcontrib>Guo, Qianqian</creatorcontrib><creatorcontrib>Wang, Xiaoqian</creatorcontrib><creatorcontrib>Wang, Qiang</creatorcontrib><creatorcontrib>Chen, Liangkai</creatorcontrib><creatorcontrib>Sun, Taoping</creatorcontrib><creatorcontrib>Li, Peiyun</creatorcontrib><creatorcontrib>Shan, Zhilei</creatorcontrib><creatorcontrib>Liu, Liegang</creatorcontrib><creatorcontrib>Gao, Chao</creatorcontrib><creatorcontrib>Rong, Ying</creatorcontrib><title>Plasma Transthyretin Levels and Risk of Type 2 Diabetes Mellitus and Impaired Glucose Regulation in a Chinese Population</title><title>Nutrients</title><addtitle>Nutrients</addtitle><description>Plasma transthyretin may be engaged in glucose regulation. We aimed to investigate the association between plasma transthyretin levels and the risk of newly diagnosed T2DM and impaired glucose regulation (IGR) in a Chinese population. We conducted a case-control study including 1244 newly diagnosed T2DM patients, 837 newly diagnosed IGR patients, and 1244 individuals with normal glucose tolerance (NGT) matched by sex and age. Multivariate logistic regression analysis was utilized to estimate the independent association of plasma transthyretin concentrations with the risk of T2DM and IGR. Plasma transthyretin concentrations were significantly higher in T2DM and IGR patients compared with control subjects (p &lt; 0.005). After multiple adjustment and comparison with the lowest quartile of plasma transthyretin concentrations, the odds ratios (95% confidence intervals) of T2DM and IGR in the highest quartile were 2.22 (1.66, 2.98) and 2.29 (1.72, 3.05), respectively. Plasma transthyretin concentrations also showed a great performance in predicting the risk of T2DM (AUC: 0.76). Moreover, a potential nonlinear trend was observed. Our results demonstrated that higher plasma transthyretin concentrations, especially more than 290 mg/L, were associated with an increased risk of T2DM and IGR. Further studies are warranted to confirm our findings and elucidate the potential mechanisms.</description><subject>Age</subject><subject>Blood Glucose - analysis</subject><subject>Body mass index</subject><subject>Case-Control Studies</subject><subject>China - epidemiology</subject><subject>Cholesterol</subject><subject>Confidence intervals</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diabetes Mellitus, Type 2 - epidemiology</subject><subject>Family medical history</subject><subject>Glucose</subject><subject>Glucose Intolerance - epidemiology</subject><subject>Glucose tolerance</subject><subject>Health risks</subject><subject>High density lipoprotein</subject><subject>Homeostasis</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Insulin resistance</subject><subject>Lipoproteins</subject><subject>Nutritional status</subject><subject>Plasma</subject><subject>Population</subject><subject>Prealbumin - analysis</subject><subject>Proteins</subject><subject>Regression analysis</subject><subject>Risk</subject><subject>Statistical analysis</subject><subject>Transthyretin</subject><issn>2072-6643</issn><issn>2072-6643</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkdFrFDEQxhdRbKl98Q-QgC8iXM0m2WTzIshVa-GKpZzPYXZ30kvdTdZkt3j_vTnuWmvzMmHmx8d88xXF25Keca7pJz-XohRMV_xFccyoYgspBX_55H9UnKZ0R3dPUSX56-KIV3WtdUmPiz_XPaQByDqCT9NmG3FynqzwHvtEwHfkxqVfJFiy3o5IGDl30OCEiVxh37tp3kOXwwguYkcu-rkNCckN3s49TC54kuWALDfOY-5fh_HQf1O8stAnPD3Uk-Lnt6_r5ffF6sfF5fLLatEKKqcFNlK0VtuK0mzFVhpYVyuBHRPQicbWlFfQqKrUtgYQStXKtsqCtILWkpX8pPi81x3nZsCuRT9F6M0Y3QBxawI48__Eu425DfdGc1bWssoCHw4CMfyeMU1mcKnN7sFjmJNhUlcsX1OqjL5_ht6FOfpsb0cJykvFaKY-7qk2hpQi2sdlSmp2mZp_mWb43dP1H9GHBPlftYCdIg</recordid><startdate>20220719</startdate><enddate>20220719</enddate><creator>Hu, Xiaoli</creator><creator>Guo, Qianqian</creator><creator>Wang, Xiaoqian</creator><creator>Wang, Qiang</creator><creator>Chen, Liangkai</creator><creator>Sun, Taoping</creator><creator>Li, Peiyun</creator><creator>Shan, Zhilei</creator><creator>Liu, Liegang</creator><creator>Gao, Chao</creator><creator>Rong, Ying</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7029-1224</orcidid><orcidid>https://orcid.org/0000-0002-8561-7872</orcidid><orcidid>https://orcid.org/0000-0002-4019-2743</orcidid></search><sort><creationdate>20220719</creationdate><title>Plasma Transthyretin Levels and Risk of Type 2 Diabetes Mellitus and Impaired Glucose Regulation in a Chinese Population</title><author>Hu, Xiaoli ; Guo, Qianqian ; Wang, Xiaoqian ; Wang, Qiang ; Chen, Liangkai ; Sun, Taoping ; Li, Peiyun ; Shan, Zhilei ; Liu, Liegang ; Gao, Chao ; Rong, Ying</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c406t-eb64cf9f500643f59a2d874ed24ad4bf8035ab7519f8aa47787fc7fa6f4086213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Age</topic><topic>Blood Glucose - analysis</topic><topic>Body mass index</topic><topic>Case-Control Studies</topic><topic>China - epidemiology</topic><topic>Cholesterol</topic><topic>Confidence intervals</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diabetes Mellitus, Type 2 - epidemiology</topic><topic>Family medical history</topic><topic>Glucose</topic><topic>Glucose Intolerance - epidemiology</topic><topic>Glucose tolerance</topic><topic>Health risks</topic><topic>High density lipoprotein</topic><topic>Homeostasis</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Insulin resistance</topic><topic>Lipoproteins</topic><topic>Nutritional status</topic><topic>Plasma</topic><topic>Population</topic><topic>Prealbumin - analysis</topic><topic>Proteins</topic><topic>Regression analysis</topic><topic>Risk</topic><topic>Statistical analysis</topic><topic>Transthyretin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hu, Xiaoli</creatorcontrib><creatorcontrib>Guo, Qianqian</creatorcontrib><creatorcontrib>Wang, Xiaoqian</creatorcontrib><creatorcontrib>Wang, Qiang</creatorcontrib><creatorcontrib>Chen, Liangkai</creatorcontrib><creatorcontrib>Sun, Taoping</creatorcontrib><creatorcontrib>Li, Peiyun</creatorcontrib><creatorcontrib>Shan, Zhilei</creatorcontrib><creatorcontrib>Liu, Liegang</creatorcontrib><creatorcontrib>Gao, Chao</creatorcontrib><creatorcontrib>Rong, Ying</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nutrients</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hu, Xiaoli</au><au>Guo, Qianqian</au><au>Wang, Xiaoqian</au><au>Wang, Qiang</au><au>Chen, Liangkai</au><au>Sun, Taoping</au><au>Li, Peiyun</au><au>Shan, Zhilei</au><au>Liu, Liegang</au><au>Gao, Chao</au><au>Rong, Ying</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma Transthyretin Levels and Risk of Type 2 Diabetes Mellitus and Impaired Glucose Regulation in a Chinese Population</atitle><jtitle>Nutrients</jtitle><addtitle>Nutrients</addtitle><date>2022-07-19</date><risdate>2022</risdate><volume>14</volume><issue>14</issue><spage>2953</spage><pages>2953-</pages><issn>2072-6643</issn><eissn>2072-6643</eissn><abstract>Plasma transthyretin may be engaged in glucose regulation. We aimed to investigate the association between plasma transthyretin levels and the risk of newly diagnosed T2DM and impaired glucose regulation (IGR) in a Chinese population. We conducted a case-control study including 1244 newly diagnosed T2DM patients, 837 newly diagnosed IGR patients, and 1244 individuals with normal glucose tolerance (NGT) matched by sex and age. Multivariate logistic regression analysis was utilized to estimate the independent association of plasma transthyretin concentrations with the risk of T2DM and IGR. Plasma transthyretin concentrations were significantly higher in T2DM and IGR patients compared with control subjects (p &lt; 0.005). After multiple adjustment and comparison with the lowest quartile of plasma transthyretin concentrations, the odds ratios (95% confidence intervals) of T2DM and IGR in the highest quartile were 2.22 (1.66, 2.98) and 2.29 (1.72, 3.05), respectively. Plasma transthyretin concentrations also showed a great performance in predicting the risk of T2DM (AUC: 0.76). Moreover, a potential nonlinear trend was observed. Our results demonstrated that higher plasma transthyretin concentrations, especially more than 290 mg/L, were associated with an increased risk of T2DM and IGR. Further studies are warranted to confirm our findings and elucidate the potential mechanisms.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35889910</pmid><doi>10.3390/nu14142953</doi><orcidid>https://orcid.org/0000-0002-7029-1224</orcidid><orcidid>https://orcid.org/0000-0002-8561-7872</orcidid><orcidid>https://orcid.org/0000-0002-4019-2743</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2072-6643
ispartof Nutrients, 2022-07, Vol.14 (14), p.2953
issn 2072-6643
2072-6643
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9321865
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; PubMed Central
subjects Age
Blood Glucose - analysis
Body mass index
Case-Control Studies
China - epidemiology
Cholesterol
Confidence intervals
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - epidemiology
Family medical history
Glucose
Glucose Intolerance - epidemiology
Glucose tolerance
Health risks
High density lipoprotein
Homeostasis
Hospitals
Humans
Hypertension
Insulin resistance
Lipoproteins
Nutritional status
Plasma
Population
Prealbumin - analysis
Proteins
Regression analysis
Risk
Statistical analysis
Transthyretin
title Plasma Transthyretin Levels and Risk of Type 2 Diabetes Mellitus and Impaired Glucose Regulation in a Chinese Population
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T22%3A41%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20Transthyretin%20Levels%20and%20Risk%20of%20Type%202%20Diabetes%20Mellitus%20and%20Impaired%20Glucose%20Regulation%20in%20a%20Chinese%20Population&rft.jtitle=Nutrients&rft.au=Hu,%20Xiaoli&rft.date=2022-07-19&rft.volume=14&rft.issue=14&rft.spage=2953&rft.pages=2953-&rft.issn=2072-6643&rft.eissn=2072-6643&rft_id=info:doi/10.3390/nu14142953&rft_dat=%3Cproquest_pubme%3E2695289967%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2694031720&rft_id=info:pmid/35889910&rfr_iscdi=true